HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 166 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $40,000 | +14.3% | 2,000 | 0.0% | 0.02% | +6.2% |
| Q3 2017 | $35,000 | +34.6% | 2,000 | 0.0% | 0.02% | +14.3% |
| Q2 2017 | $26,000 | 0.0% | 2,000 | 0.0% | 0.01% | +7.7% |
| Q1 2017 | $26,000 | +30.0% | 2,000 | 0.0% | 0.01% | +44.4% |
| Q4 2016 | $20,000 | -16.7% | 2,000 | 0.0% | 0.01% | -47.1% |
| Q3 2016 | $24,000 | +26.3% | 2,000 | 0.0% | 0.02% | +21.4% |
| Q2 2016 | $19,000 | -5.0% | 2,000 | 0.0% | 0.01% | -6.7% |
| Q1 2016 | $20,000 | -42.9% | 2,000 | 0.0% | 0.02% | -40.0% |
| Q4 2015 | $35,000 | +25.0% | 2,000 | 0.0% | 0.02% | +13.6% |
| Q3 2015 | $28,000 | -37.8% | 2,000 | 0.0% | 0.02% | -35.3% |
| Q2 2015 | $45,000 | +55.2% | 2,000 | 0.0% | 0.03% | +54.5% |
| Q1 2015 | $29,000 | +52.6% | 2,000 | 0.0% | 0.02% | +15.8% |
| Q4 2014 | $19,000 | – | 2,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SNYDER CAPITAL MANAGEMENT L P | 4,324,232 | $165,185,662 | 3.73% |
| Steamboat Capital Partners, LLC | 196,898 | $7,521,504 | 2.79% |
| 2Xideas AG | 600,799 | $22,950,522 | 2.54% |
| BERNZOTT CAPITAL ADVISORS | 171,808 | $6,563,066 | 2.26% |
| Redwood Investments, LLC | 328,459 | $12,547,134 | 1.70% |
| Mesirow Institutional Investment Management, Inc. | 380,415 | $14,531,853 | 1.47% |
| Granite Investment Partners, LLC | 856,253 | $32,708,865 | 1.37% |
| Penn Capital Management Company, LLC | 324,707 | $12,453,211 | 1.28% |
| EFG Asset Management (North America) Corp. | 137,739 | $5,262,319 | 1.25% |
| First Light Asset Management, LLC | 313,536 | $11,977,075 | 1.14% |